As a prelude to molecular modeling and other studies of the newly clon
ed and expressed mu, delta and kappa opioid receptor subtypes, X-Ray c
rystal structures were determined for etonitazene, (1) cis-(+)-3-methy
lfentanyl (4) and etorphine (6), three extremely potent opioid agonist
s. X-Ray crystal structures were also determined for diprenorphine 7,
a potent opioid antagonist, and buprenorphine (8), a clinically useful
mixed agonist-antagonist. Agonists (1), (4) and (6) are structurally
diverse but have similar profiles while (7) and (8) have substantially
different pharmacological profiles but differ structurally by only a
methyl vs. a tertbutyl function. The present results should facilitate
studies toward understanding the differences which underlie these obs
ervations on a molecular basis.